Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 40 pages

Potassium Voltage Gated Channel Subfamily H Member 2 (HERG or Voltage Gated Potassium Channel Subunit Kv11.1 or Eag Homolog or KCNH2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Potassium Voltage Gated Channel Subfamily H Member 2 (HERG or Voltage Gated Potassium Channel Subunit Kv11.1 or Eag Homolog or KCNH2) Drugs in Development by Therapy Areas and Indications, Stages, MoA...

May 2022 37 pages

Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pouchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 41 pages

Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pre-Eclampsia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 42 pages

Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Premature Ovarian Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 39 pages

Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 41 pages

Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 55 pages

Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Hyperoxaluria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 44 pages

Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Hyperoxaluria Type I Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 38 pages

Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target,...

May 2022 129 pages

Primary Progressive Multiple Sclerosis (PPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primary Progressive Multiple Sclerosis (PPMS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primary Progressive Multiple Sclerosis (PPMS) Drugs in Development...

May 2022 55 pages

Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Ta...

May 2022 43 pages

Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Proctitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 37 pages

Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Progesterone Receptor (Nuclear Receptor Subfamily 3 Group C Member 3 or NR3C3 or PGR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Pro...

May 2022 81 pages

Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Programmed Cell Death 1 Ligand 1 (PD L1 or B7 Homolog 1 or CD274) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Programmed Cell Death 1...

May 2022 274 pages

Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Programmed Cel...

May 2022 40 pages

Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Programmed Cell Death Protein 1 (PD1 or CD279 or PDCD1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Programmed Cell Death Protein 1 (...

May 2022 234 pages

Progressive Familial Intrahepatic Cholestasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Progressive Familial Intrahepatic Cholestasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Progressive Familial Intrahepatic Cholestasis Drugs in Development...

May 2022 38 pages

Prolow Density Lipoprotein Receptor Related Protein 1 (Alpha 2 Macroglobulin Receptor or Apolipoprotein E Receptor or CD91 or LRP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prolow Density Lipoprotein Receptor Related Protein 1 (Alpha 2 Macroglobulin Receptor or Apolipoprotein E Receptor or CD91 or LRP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA,...

May 2022 35 pages

Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Prolyl Endope...

May 2022 35 pages

Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Propionic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 41 pages

Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or PTGIR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or PTGIR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Pros...

May 2022 54 pages

Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prostaglandin E2 Receptor EP1 Subtype (Prostanoid EP1 Receptor or PTGER1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Prostaglandin E...

May 2022 50 pages

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Prostaglandin E...

May 2022 37 pages

Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Prostaglandin F2 Alpha...

May 2022 53 pages

Prostaglandin G-H Synthase 1 (Cyclooxygenase 1 or COX1 or Prostaglandin Endoperoxide Synthase 1 or Prostaglandin H2 Synthase 1 or PTGS1 or EC 1.14.99.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prostaglandin G-H Synthase 1 (Cyclooxygenase 1 or COX1 or Prostaglandin Endoperoxide Synthase 1 or Prostaglandin H2 Synthase 1 or PTGS1 or EC 1.14.99.1) Drugs in Development by Therapy Areas and Indic...

May 2022 127 pages

Prostaglandin G-H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Prostaglandin G-H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) Drugs in Development by Therapy Areas...

May 2022 183 pages

Prostaglandin G-H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Prostaglandin G-H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Prostaglandin...

May 2022 200 pages

Protein Cysteine N Palmitoyltransferase Porcupine (Protein MG61 or PORCN or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Protein Cysteine N Palmitoyltransferase Porcupine (Protein MG61 or PORCN or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Pr...

May 2022 36 pages

Protein Kinase B (PKB or AKT or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Protein Kinase B (PKB or AKT or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Protein Kinase B (PKB or AKT or EC 2.7.11.1)...

May 2022 71 pages

Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 37 pages

Protein Kinase C (PKC or PRKC or EC 2.7.11.13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Protein Kinase C (PKC or PRKC or EC 2.7.11.13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Protein Kinase C (PKC or PRKC or EC 2.7.11...

May 2022 83 pages

Protein Tyrosine Phosphatase (EC 3.1.3.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Protein Tyrosine Phosphatase (EC 3.1.3.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Protein Tyrosine Phosphatase (EC 3.1.3.48) Dru...

May 2022 117 pages

Proteinase Activated Receptor 1 (PAR1 or Coagulation Factor II Receptor or Thrombin Receptor or F2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Proteinase Activated Receptor 1 (PAR1 or Coagulation Factor II Receptor or Thrombin Receptor or F2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 38 pages

Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Prothrombin (Coagulation Factor...

May 2022 49 pages

Proto Oncogene Mas (MAS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Proto Oncogene Mas (MAS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Proto Oncogene Mas (MAS1) Drugs in Development by Therapy Areas...

May 2022 38 pages

Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Prurigo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 41 pages

Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pseudomonas Aeruginosa Infections Drugs in Development by Stages, Target, MoA,...

May 2022 180 pages

Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pseudomonas Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 192 pages

Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Psychosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 61 pages

Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 180 pages

Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 53 pages

Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Radiation Toxicity Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 38 pages

Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pulmonary Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 51 pages

Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Q Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 35 pages

Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 39 pages

Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Radiculopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 35 pages

Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ras (EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications,...

May 2022 197 pages

Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Raynauds Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 37 pages

Receptor Activity Modifying Protein 1 (Calcitonin Receptor Like Receptor Activity Modifying Protein 1 or RAMP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Receptor Activity Modifying Protein 1 (Calcitonin Receptor Like Receptor Activity Modifying Protein 1 or RAMP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type a...

May 2022 38 pages

Filters

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

Date

Pages

Offers

1
280
1
1